2016 American Transplant Congress

Sunday, June 12, 2016

5:30pm-5:42pm

Intracellular OPN Is an Essential Protective Factor for Cardiac Endothelial Cell and the Long Term Heart Graft Survival.

Y. Su,^1,2,3 Z.-X. Zhang,^1,2,3 Z.-Q. Yin,¹ X.-Y. Huang,¹ A. Jevnikar.^1,2,3,4

Concurrent Session: Chronic Allograft Rejection: Animal Models  •  Room 309

5:30pm-5:42pm

Rapid Detection of Urinary CXCL9 as a Diagnostic and Prognostic Tool for Managing Acute Cellular Rejection (ACR) in Kidney Transplantation.

I. Gandolfini,¹ C. Harris,¹ C. Purroy,¹ V. Nair,¹ J. Reid-Adam,¹ O. Bestard,² P. Heeger.¹

Concurrent Session: Kidney Immune Monitoring 1  •  Ballroom C

5:30pm-5:42pm

The Influence of Rising Lab MELD on Vascular Invasion in HCC.

K. Halazun, E. Przybyszewski, E. Verna, B. Samstein, A. Fox, R. Brown, J. Emond.

Concurrent Session: Hepatic Malignancies  •  Room 304

5:30pm-5:42pm

Utility of Six-Minute-Walk Distance in Predicting Lung Transplant Benefit in the Lung Allocation Score Era.

S. Shah,¹ D. Tumin,³ B. Whitson,² A. Pope-Harman,¹ S. Kirkby,¹ A. Kilic,² P. Lee,² D. Hayes.^1,3

Concurrent Session: Lung Transplant: Moving the Field Forward  •  Room 313

5:42pm-5:54pm

Everolimus versus Mycophenolate Mofetil in Combination with Tacrolimus: A Propensity Score Matching Analysis in Liver Transplantation.

P. de Simone,¹ P. Carrai,¹ A. Precisi,² L. Coletti,¹ D. Ghinolfi,¹ F. Filipponi.¹

Concurrent Session: Liver: Immunosuppression and Rejection  •  Room 312

5:42pm-5:54pm

Hif-1α Stabilization in the Recipient Accelerates Cardiac Allograft Rejection.

Z. Ilyas, M. DeBerge, S. Dehn, J.-J. Wang, Z. Zhang, E. Thorp, M. Ansari.

Concurrent Session: Chronic Allograft Rejection: Animal Models  •  Room 309

5:42pm-5:54pm

Implications of Subclinical Borderline Acute Cellular Rejection Detected in Protocol Biopsies on Graft Outcomes.

Z. Zaky,¹ C. Yu,¹ N. Elfadawy,² A. Chiesa-Vottero,¹ L. Herlitz,¹ S. Flechner,¹ E. Poggio.¹

Concurrent Session: Kidney Immune Monitoring 1  •  Ballroom C

5:42pm-5:54pm

Infectious Complication in Extremely Elderly Kidney Transplant (KT) Recipients: A Leading Cause of Death.

J. Cabrera,^1,3 M. Fernández-Ruiz,² M. Molina,¹ E. González,¹ N. Polanco,¹ F. López-Medrano,² J. Aguado,² M. Praga,¹ A. Andrés.¹

Concurrent Session: Organ Transplantation in the Era of Highly Resistant Pathogens  •  Room 311

5:42pm-5:54pm

Mechanisms of Alloantigen-Specific Regulation After Donor Specific Transfusion and Costimulatory Blockade in YFP-Foxp3/TdTomRed-Ebi3 Marker Mice.

Y. Tomita,¹ W. Bracamonte-Baran,¹ D. Vignali,² W. Burlingham.¹

Concurrent Session: Allograft Tolerance 1: Animal Models  •  Room 306

5:42pm-5:54pm

Safety of a Short (One-Year) Waiting Time in Kidney Transplant Candidates Treated for Cancer.

D. Dahle,¹ T. Grotmol,² T. Leivestad,³ A. Hartmann,¹ G. Mjøen,¹ H. Pihlstrøm,¹ H. Næss,¹ H. Holdaas.¹

Concurrent Session: Older and High Risk Kidney Transplant Recipients/Donors  •  Ballroom A